Age, years (median [IQR])
|
67 [59–75]
|
68 [59–75]
|
0.560
|
SAPS II score (median [IQR])
|
35 [31–43]
|
44 [28–51]
|
0.655
|
Male gender (% [95% CI])
|
50.0 [15.7–84.3]
|
77.8 [30.6–69.4]
|
0.197
|
ICU mortality (% [95% CI])
|
12.5 [0.3–52.7]
|
33.3 [13.3–59.0]
|
0.375
|
Ventilation hours (median [IQR])
|
353 [68–621]
|
735 [209–1508]
|
0.317
|
ICU LOS, days (median [IQR])
|
24 [3–38]
|
23 [12–59]
|
0.780
|
Hospital LOS, days (median [IQR])
|
57 [47–79]
|
54 [34–100]
|
0.824
|
SOFA score max (median [IQR])
|
11 [9–12]
|
12 [9–13]
|
0.557
|
Length of antibiotic treatment, days (median [IQR])
|
7 [6–9]
|
12 [9–16]
|
0.002
|
Antibiotic use density, DDD (median [IQR])
|
10 [7–12]
|
18 [12–26]
|
0.001
|
Initial PCT value, ng/mL (median [IQR])
|
20.0 [9.4–38.2]
|
16.8 [2.0–42.7]
|
0.560
|
Peak PCT value, ng/mL (median [IQR])
|
32.3 [9.4–64.2]
|
44.9 [13.9–69.7]
|
0.718
|